Cost‐effectiveness of screening for bowel cancer

TheNational Bowel Cancer Screening Program (NBCSP), based on a faecal occult blood test (FOBT), was introduced in mid 2006 to people aged 55 and 65 years, andwas extended in 2009 to include people aged 50 years. It is due to be further expanded to biennial testing in 2020, with gaps filled annually until then. This delay in full implementation is related to the perceived cost of the NBCSP as well as infrastructure and logistical difficulties.

[1]  Aung Ko Win,et al.  Rising incidence of early‐onset colorectal cancer in Australia over two decades: Report and review , 2015, Journal of gastroenterology and hepatology.

[2]  I. Lansdorp-Vogelaar,et al.  Optimising the expansion of the National Bowel Cancer Screening Program , 2014, The Medical journal of Australia.

[3]  T. Bolin,et al.  Further Evidence to Lower the Recommended Screening Age for Colorectal Cancer: 2078 , 2013 .

[4]  Mark Woodward,et al.  The impact of dietary and lifestyle risk factors on risk of colorectal cancer: A quantitative overview of the epidemiological evidence , 2009, International journal of cancer.

[5]  D. Hüppe,et al.  Screening colonoscopy for colorectal cancer prevention: results from a German online registry on 269 000 cases , 2009, European journal of gastroenterology & hepatology.

[6]  William K K Wu,et al.  Cigarette smoking and the risk of colorectal cancer: a meta-analysis of prospective cohort studies. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[7]  R. Goldbohm,et al.  Alcohol consumption, type of alcoholic beverage and risk of colorectal cancer at specific subsites , 2008, International journal of cancer.

[8]  D. Ransohoff.  What is the role of iFOBT in screening for colorectal cancer? , 2007, Gut.

[9]  S. Cole,et al.  Comparison of a brush‐sampling fecal immunochemical test for hemoglobin with a sensitive guaiac‐based fecal occult blood test in detection of colorectal neoplasia , 2006, Cancer.

[10]  Y. Eishi,et al.  Screening for colorectal cancer in Uruguay with an immunochemical faecal occult blood test , 2006, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[11]  P. Bampton,et al.  A comparison of colorectal neoplasia screening tests: a multicentre community‐based study of the impact of consumer choice , 2006 .

[12]  Keith R. Abrams,et al.  Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease. , 2006 .

[13]  R. Nozaki,et al.  COMMUNITY‐BASED MASS SCREENING FOR COLORECTAL CANCER BY A COMBINATION OF FECAL OCCULT BLOOD TESTING AND FLEXIBLE SIGMOIDOSCOPY , 2006 .

[14]  E. Hanisch,et al.  Comparative evaluation of a new bedside faecal occult blood test in a prospective multicentre study , 2006, Alimentary pharmacology & therapeutics.

[15]  Paolo Vineis,et al.  Meat, fish, and colorectal cancer risk: the European Prospective Investigation into cancer and nutrition. , 2005, Journal of the National Cancer Institute.

[16]  B. Shadbolt,et al.  Colonoscopy screening for colorectal cancer: the outcomes of two recruitment methods , 2004, The Medical journal of Australia.

[17]  A. Rothberg.  Making Choices in Health: WHO Guide to Cost Effectiveness Analysis , 2008 .

[18]  W. Willett,et al.  Alcohol Intake and Colorectal Cancer: A Pooled Analysis of 8 Cohort Studies , 2004, Annals of Internal Medicine.

[19]  S. Crotta,et al.  Feasibility study of colorectal cancer screening by immunochemical faecal occult blood testing: results in a northern Italian community , 2004, European journal of gastroenterology & hepatology.

[20]  A. Neville,et al.  Cost‐effectiveness of colorectal cancer screening: Comparison of community‐based flexible sigmoidoscopy with fecal occult blood testing and colonoscopy , 2004, Journal of gastroenterology and hepatology.

[21]  C. Viiala,et al.  Complication rates of colonoscopy in an Australian teaching hospital environment , 2003, Internal medicine journal.

[22]  M. Yuen,et al.  Evaluation of an automated immunochemical fecal occult blood test for colorectal neoplasia detection in a Chinese population , 2003, Cancer.

[23]  Paolo Vineis,et al.  Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study , 2003, The Lancet.

[24]  Alan D. Lopez,et al.  The burden of disease and injury in Australia. , 2001, Bulletin of the World Health Organization.

[25]  J. Olynyk,et al.  Fecal occult blood and flexible sigmoidoscopy screening for colorectal cancer: Modeling the impact on colonoscopy requirements and cancer detection rates , 2001, Journal of gastroenterology and hepatology.

[26]  H. Lapsley,et al.  Screening for colorectal cancer: what is the most cost‐effective approach? , 2001, The Medical journal of Australia.

[27]  P. Dickman,et al.  Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study , 2001, The Lancet.

[28]  Ann M Holmes,et al.  Cost-utility of one-time colonoscopic screening for colorectal cancer at various ages , 2000, American Journal of Gastroenterology.

[29]  H. Nakama,et al.  Cost-effectiveness analysis of immunochemical occult blood screening for colorectal cancer among three fecal sampling methods. , 2000, Hepato-gastroenterology.

[30]  J. Taylor,et al.  Interactions of familial and hormonal risk factors for large bowel cancer in women. , 1999, International journal of epidemiology.

[31]  V. Hasselblad,et al.  Hormone replacement therapy and the risk of colorectal cancer: a meta-analysis. , 1999, Obstetrics and gynecology.

[32]  Donnelly,et al.  Positive cost effectiveness of early diagnosis of colorectal cancer , 1999, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[33]  D. Whynes,et al.  Faecal occult blood screening for colorectal cancer: is it cost-effective? , 1998, Health economics.

[34]  K. Kinzler,et al.  Analysis of mismatch repair genes in hereditary non–polyposis colorectal cancer patients , 1996, Nature Medicine.

[35]  J. Potter.  Risk factors for colon neoplasia--epidemiology and biology. , 1995, European journal of cancer.

[36]  H. Adami,et al.  Ulcerative colitis and colorectal cancer. A population-based study. , 1990, The New England journal of medicine.

[37]  J. Barkin.  A Quantitative Immunochemical Fecal Occult Blood Test for Colorectal Neoplasia , 2008 .

[38]  T. Morikawa,et al.  A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. , 2005, Gastroenterology.

[39]  B. Levin,et al.  Emerging Technologies in Screening for Colorectal Cancer: CT Colonography, Immunochemical Fecal Occult Blood Tests, and Stool Screening Using Molecular Markers , 2003, CA: a cancer journal for clinicians.